Although an elevated platelet count is observed at presentation in a number of CML patients, marked thrombocytosis (platelets > 1000 × 109/L) is uncommon and often associated with the e19a2 BCR-ABL1 transcript type [14]. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.